CN1061341A - 用作抗病毒药物的噻唑并异二氢氮杂茚酮衍生物) - Google Patents

用作抗病毒药物的噻唑并异二氢氮杂茚酮衍生物) Download PDF

Info

Publication number
CN1061341A
CN1061341A CN91110726A CN91110726A CN1061341A CN 1061341 A CN1061341 A CN 1061341A CN 91110726 A CN91110726 A CN 91110726A CN 91110726 A CN91110726 A CN 91110726A CN 1061341 A CN1061341 A CN 1061341A
Authority
CN
China
Prior art keywords
phenyl
logical formula
compound
thiazoline
indoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN91110726A
Other languages
English (en)
Chinese (zh)
Inventor
H·齐尔希
A·梅尔滕斯
H·莱纳特
U·莱泽
B·柯尼希
H·塞德尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of CN1061341A publication Critical patent/CN1061341A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN91110726A 1990-11-10 1991-11-09 用作抗病毒药物的噻唑并异二氢氮杂茚酮衍生物) Pending CN1061341A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4035809.7 1990-11-10
DE4035809A DE4035809A1 (de) 1990-11-10 1990-11-10 Verwendung von thiazoloisoindolinon-derivaten als antivirale arzneimittel

Publications (1)

Publication Number Publication Date
CN1061341A true CN1061341A (zh) 1992-05-27

Family

ID=6418011

Family Applications (1)

Application Number Title Priority Date Filing Date
CN91110726A Pending CN1061341A (zh) 1990-11-10 1991-11-09 用作抗病毒药物的噻唑并异二氢氮杂茚酮衍生物)

Country Status (16)

Country Link
US (1) US5397794A (cg-RX-API-DMAC10.html)
EP (1) EP0556245B1 (cg-RX-API-DMAC10.html)
JP (1) JPH06501690A (cg-RX-API-DMAC10.html)
CN (1) CN1061341A (cg-RX-API-DMAC10.html)
AT (1) ATE117552T1 (cg-RX-API-DMAC10.html)
AU (1) AU8865091A (cg-RX-API-DMAC10.html)
CA (1) CA2095249A1 (cg-RX-API-DMAC10.html)
DE (2) DE4035809A1 (cg-RX-API-DMAC10.html)
ES (1) ES2069313T3 (cg-RX-API-DMAC10.html)
IE (1) IE913898A1 (cg-RX-API-DMAC10.html)
IL (1) IL99989A0 (cg-RX-API-DMAC10.html)
MX (1) MX9101948A (cg-RX-API-DMAC10.html)
PT (1) PT99463A (cg-RX-API-DMAC10.html)
TW (1) TW198680B (cg-RX-API-DMAC10.html)
WO (1) WO1992008457A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA918862B (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105121433A (zh) * 2012-12-14 2015-12-02 韩国化学研究院 新型化合物、其药学上可接受的盐或光学异构体、用于制备它们的方法以及包含它们作为有效成分的用于预防或治疗病毒性疾病的药物组合物
CN116283657A (zh) * 2023-02-22 2023-06-23 贵州大学 一种茚酮衍生物及其合成方法和应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4129779A1 (de) * 1991-09-07 1993-03-11 Boehringer Mannheim Gmbh Neue tricyclische thiazol- und oxazol-derivate und diese enthaltende arzneimittel
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US20040254635A1 (en) 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
DE20122506U1 (de) 2000-10-16 2005-12-08 Conor Medsystems, Inc., Menlo Park Ausdehnbare medizinische Vorrichtung zur Abgabe eines nützlichen Agens
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334113A (en) * 1963-12-18 1967-08-01 Sandoz Ag 9b-phenyl-1, 2, 3, 9b-tetrahydro-5h-imidazo[2,1-a]isoindol-5-ones

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105121433A (zh) * 2012-12-14 2015-12-02 韩国化学研究院 新型化合物、其药学上可接受的盐或光学异构体、用于制备它们的方法以及包含它们作为有效成分的用于预防或治疗病毒性疾病的药物组合物
CN105121433B (zh) * 2012-12-14 2018-01-23 韩国化学研究院 抗病毒化合物、其药学上可接受的盐或光学异构体、用于制备它们的方法以及包含它们作为有效成分的用于预防或治疗病毒性疾病的药物组合物
CN116283657A (zh) * 2023-02-22 2023-06-23 贵州大学 一种茚酮衍生物及其合成方法和应用

Also Published As

Publication number Publication date
TW198680B (cg-RX-API-DMAC10.html) 1993-01-21
US5397794A (en) 1995-03-14
ZA918862B (en) 1992-08-26
IL99989A0 (en) 1992-08-18
EP0556245B1 (de) 1995-01-25
DE4035809A1 (de) 1992-05-14
PT99463A (pt) 1992-09-30
WO1992008457A1 (de) 1992-05-29
DE59104441D1 (de) 1995-03-09
MX9101948A (es) 1992-07-08
IE913898A1 (en) 1992-05-20
ES2069313T3 (es) 1995-05-01
AU8865091A (en) 1992-06-11
ATE117552T1 (de) 1995-02-15
CA2095249A1 (en) 1992-05-11
JPH06501690A (ja) 1994-02-24
EP0556245A1 (de) 1993-08-25

Similar Documents

Publication Publication Date Title
RU2142946C1 (ru) Производные пиразола и фармацевтическая композиция, содержащая их
CN1195526C (zh) 含对映体纯β－D－二氧戊环核苷的药物产品
CN1076021C (zh) 作为抗乙肝(hbv)及抗hiv药物的l－2',3',－二去氧核苷类似物
EP0103497A1 (fr) Nouveaux dérivés de la xanthine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
CN1159305C (zh) 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物
CN1061341A (zh) 用作抗病毒药物的噻唑并异二氢氮杂茚酮衍生物)
EP0109866B1 (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
JP2577442B2 (ja) 新規インドリルプロパノール及びその製造方法
JPS6340784B2 (cg-RX-API-DMAC10.html)
EP0117959B1 (fr) Nouveaux dérivés de la nitrosourée, leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP0463944B1 (fr) Acyl benzoxazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CN1024798C (zh) 制备新的碱性基取代的5-卤代-噻吩并异噻唑-3(2h)-酮1，1-二氧化物的方法
CN1081442A (zh) 苯并二氮杂䓬
CN1181822C (zh) 2－氨基－3,4－二氢喹唑啉类在生产用于治疗或预防因局部缺血情况导致的疾病的药物中的用途
FR2572285A1 (fr) Medicaments a base de nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine
JPH0892248A (ja) インドリノン誘導体
CN1021820C (zh) N9-取代的腺嘌呤n1-取代的胞嘧啶的制备方法
CN1023484C (zh) 4-(2-嘧啶基)-1-哌嗪基杂环羰基衍生物的制备方法
EP0395526B1 (fr) Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CN1065529C (zh) 4－喹啉酮衍生物及其盐
EP0233804B1 (fr) Monoaryl-5 as triazinones-3 substituées en position 2, leur procédé de préparation et leur application en tant que medicaments
GB1580001A (en) Therapeutically active 1 - phenyl - 1 - methoxy - 2-aminothane derivatives
FR2531709A1 (fr) Diazabicyclooctanes, procede pour leur preparation et compositions pharmaceutiques les renfermant
JPS63275572A (ja) １，５−ベンゾチアゼピン誘導体
CN1017151B (zh) 萘并硫杂氮衍生物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication